J R Schriber

548 total citations
9 papers, 321 citations indexed

About

J R Schriber is a scholar working on Hematology, Surgery and Genetics. According to data from OpenAlex, J R Schriber has authored 9 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 3 papers in Surgery and 2 papers in Genetics. Recurrent topics in J R Schriber's work include Hematopoietic Stem Cell Transplantation (3 papers), Acute Myeloid Leukemia Research (2 papers) and Multiple Myeloma Research and Treatments (2 papers). J R Schriber is often cited by papers focused on Hematopoietic Stem Cell Transplantation (3 papers), Acute Myeloid Leukemia Research (2 papers) and Multiple Myeloma Research and Treatments (2 papers). J R Schriber collaborates with scholars based in United States, Sweden and Canada. J R Schriber's co-authors include GP Herzig, G D Long, KG Blume, RS Negrin, Olle Ringdén, Richard F. Olsson, Görgün Akpek, C. Kusnierz-Glaz, D I Marks and M Amylon and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Leukemia.

In The Last Decade

J R Schriber

9 papers receiving 308 citations

Peers

J R Schriber

HEMAT

ONCOL

IMMUN

TRANS

GENET

Sara Mach‐Pascual Switzerland

Bernadette Heizel M. Reyes Philippines

Julie Milojevic Switzerland

Corentin Orvain France

Ozan Salim Türkiye

Margaret Michalska United States

D. Schaumann Germany

Jaime Garcı́a-Chávez Mexico

A. M. Patterson United Kingdom

Erik Schadde United States

Sara Mach‐Pascual Switzerland

J R Schriber

218 ×1.2

HEMAT

25 ×0.3

ONCOL

73 ×0.8

IMMUN

23 ×0.5

TRANS

161 ×3.9

GENET

Citations per year, relative to J R Schriber J R Schriber (= 1×) peers Sara Mach‐Pascual

Countries citing papers authored by J R Schriber

Since Specialization

Citations

This map shows the geographic impact of J R Schriber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J R Schriber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J R Schriber more than expected).

Fields of papers citing papers by J R Schriber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J R Schriber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J R Schriber. The network helps show where J R Schriber may publish in the future.

Co-authorship network of co-authors of J R Schriber

This figure shows the co-authorship network connecting the top 25 collaborators of J R Schriber. A scholar is included among the top collaborators of J R Schriber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J R Schriber. J R Schriber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Olsson, Richard F., Brent R. Logan, Sonali Chaudhury, et al.. (2015). Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. Leukemia. 29(8). 1754–1762. 78 indexed citations

Horwitz, Mitchell E., G D Long, Peter Holman, et al.. (2012). Efficacy and safety of hematopoietic stem cell remobilization with plerixafor+G-CSF in adult patients with germ cell tumors. Bone Marrow Transplantation. 47(10). 1283–1286. 13 indexed citations

Morgan, R.J., L. Leong, J R Schriber, et al.. (2001). Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer. Bone Marrow Transplantation. 28(9). 859–863. 6 indexed citations

Somlo, George, James H. Doroshow, Timothy W. Synold, et al.. (2001). High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome. British Journal of Cancer. 84(12). 1591–1598. 26 indexed citations

Schriber, J R, Darcy H. Shaw, Neal P. Christiansen, et al.. (1999). Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation. Bone Marrow Transplantation. 24(12). 1311–1314. 26 indexed citations

Schriber, J R, et al.. (1998). The effect of human leukocyte antigen disparity on cyclosporine neurotoxicity after allogeneic bone marrow transplantation.. American Journal of Neuroradiology. 19(4). 601–8; discussion 609. 24 indexed citations

Kusnierz-Glaz, C., J R Schriber, N J Chao, et al.. (1997). Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies.. Journal of Clinical Oncology. 15(1). 18–25. 58 indexed citations

Schriber, J R & GP Herzig. (1997). Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.. PubMed. 34(2). 126–33. 77 indexed citations

Schriber, J R, RS Negrin, Nelson J. Chao, et al.. (1993). The efficacy of granulocyte colony-stimulating factor following autologous bone marrow transplantation for non-Hodgkin's lymphoma with monoclonal antibody purged bone marrow.. PubMed. 7(10). 1491–5. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact